Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT06993428
A Trial With EMP16 in Preparation for Late Phase Studies (POEM)
A PilOt Dose-escalation Trial With EMP16 in Preparation for Phase III - the POEM Trial
Sponsor: Empros Pharma AB
Conditions
Obesity and Overweight Overweight or Obese
Updated 1 time since 2025 Last updated: May 20, 2025 Started: May 20, 2025 Primary completion: Jul 29, 2025 Completion: Jul 29, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06993428, this PHASE2 trial focuses on Obesity and Overweight and Overweight or Obese and remains actively recruiting participants. Sponsored by Empros Pharma AB, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Empros Pharma AB
Data source: Empros Pharma AB
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.